United States

Novavax is a biotech company that develops and commercializes vaccines to protect against infectious diseases. It uses a vaccine platform that combines recombinant protein approach, nanoparticle technology, and Matrix-M adjuvant to enhance the immune response. The company is currently evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. It is commercializing a COVID-19 vaccine, NVX-CoV2373, and is also focusing on products candidates for respiratory syncytial virus and malaria. Novavax was founded in 1987 and is headquartered in Gaithersburg, Maryland.

Google

Meneja wa Bidhaa

Mwanasayansi wa Data

Novavax

Novavax Ajira Zilizo Wazi

Je, uko tayari kuboresha kazi yako? Angalia nafasi hizi zilizo wazi katika Novavax.